Sigma Healthcare's Fiscal H1 Results Strong, Jarden Research Says
MT Newswires Live
Feb 26
Sigma Healthcare's (ASX:SIG) fiscal first-half results were strong, met expectations, and showed that costs were well managed, according to a Thursday note by Jarden Research.
On Thursday, the company reported fiscal first-half normalized earnings of AU$0.034 per share and revenue of AU$5.51 billion.
The company also reported a "very strong" trading update, with second half year-to-date sales up 16.6% across Chemist Warehouse, and ahead of Jarden's expectations.
The investment firm reaffirmed an overweight rating and AU$3.60 price target on Sigma Healthcare.
Shares of Sigma Healthcare rose 2% in recent Thursday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.